Found: 32
Select item for more details and to access through your institution.
Systemic amyloidosis from A (AA) to T (ATTR): a review.
- Published in:
- Journal of Internal Medicine, 2021, v. 289, n. 3, p. 268, doi. 10.1111/joim.13169
- By:
- Publication type:
- Article
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 996, doi. 10.1038/bmt.2014.24
- By:
- Publication type:
- Article
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 201, doi. 10.1038/bmt.2013.175
- By:
- Publication type:
- Article
Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 12, p. 1543, doi. 10.1038/bmt.2013.109
- By:
- Publication type:
- Article
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 10, p. 1302, doi. 10.1038/bmt.2013.53
- By:
- Publication type:
- Article
Second auto-SCT for treatment of relapsed multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 568, doi. 10.1038/bmt.2012.183
- By:
- Publication type:
- Article
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 557, doi. 10.1038/bmt.2012.170
- By:
- Publication type:
- Article
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 970, doi. 10.1038/bmt.2010.234
- By:
- Publication type:
- Article
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 943, doi. 10.1038/bmt.2010.236
- By:
- Publication type:
- Article
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 956, doi. 10.1038/bmt.2010.233
- By:
- Publication type:
- Article
Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 291, doi. 10.1038/bmt.2010.106
- By:
- Publication type:
- Article
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 8, p. 619, doi. 10.1038/bmt.2008.369
- By:
- Publication type:
- Article
Impact of early relapse after auto-SCT for multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2008, v. 42, n. 6, p. 413, doi. 10.1038/bmt.2008.180
- By:
- Publication type:
- Article
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2008, v. 42, n. 4, p. 259, doi. 10.1038/bmt.2008.166
- By:
- Publication type:
- Article
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
- Published in:
- Bone Marrow Transplantation, 2008, v. 41, n. 12, p. 1013, doi. 10.1038/bmt.2008.24
- By:
- Publication type:
- Article
Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 8, p. 759, doi. 10.1038/sj.bmt.1705814
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
- Published in:
- Bone Marrow Transplantation, 2006, v. 37, n. 11, p. 1017, doi. 10.1038/sj.bmt.1705371
- By:
- Publication type:
- Article
Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis.
- Published in:
- Bone Marrow Transplantation, 2003, v. 31, n. 10, p. 851, doi. 10.1038/sj.bmt.1704034
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00859-x
- By:
- Publication type:
- Article
"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00592-3
- By:
- Publication type:
- Article
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 10, p. 2060, doi. 10.1038/leu.2014.98
- By:
- Publication type:
- Article
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 5, p. 1122, doi. 10.1038/leu.2013.313
- By:
- Publication type:
- Article
Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 455, doi. 10.1038/leu.2013.300
- By:
- Publication type:
- Article
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2351, doi. 10.1038/leu.2013.152
- By:
- Publication type:
- Article
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 10, p. 2062, doi. 10.1038/leu.2013.143
- By:
- Publication type:
- Article
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1119, doi. 10.1038/leu.2011.308
- By:
- Publication type:
- Article
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 839, doi. 10.1038/leu.2011.279
- By:
- Publication type:
- Article
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 9, p. 2035, doi. 10.1038/sj.leu.2404801
- By:
- Publication type:
- Article